Wednesday, February 10, 2010, 6:51am EST - Canadian Markets open in 2 hours and 39 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Charles River Laboratories International, Inc. (CRL)

 On Feb 9: 36.16 USD   0.00 (0.00%)  
MORE ON CRL
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
CHARLES RIVER LAB (NYSE:CRL) Delayed quote dataEdit
Last Trade: 36.16 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 36.16
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 38.00
Day's Range: N/A - N/A
52wk Range: 23.03 - 40.14
Volume: 0
Avg Vol (3m): 757,186
Market Cap: 2.38B
P/E (ttm): N/A
EPS (ttm): -8.57
Div & Yield: N/A (N/A%)
Charles River Laboratories International, Inc. (CRL)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add CRL to Portfolio   Download Data

HEADLINES
• Charles River Labs eyes return to growth
at bizjournals.com (Tue 3:05pm)
• Charles River Laboratories International Inc. Q4 2009 Earnings Call Transcript
at Seeking Alpha (Tue 2:38pm)
• UPDATE - Charles River sees rise in demand, shares up
at Reuters (Tue 11:29am)
• New Star Analyst Rankings for CHARLES RIVER LAB
StarMine (Tue 9:17am)
• CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
EDGAR Online (Tue 6:02am)
• UPDATE - Charles River Q4 profit tops Street view
at Reuters (Mon, Feb 8)
• Charles River reports profit, but revenue slides
AP (Mon, Feb 8)
• Charles River Announces Fourth-Quarter and Full-Year 2009 Results and Provides 2010 Guidance
Business Wire (Mon, Feb 8)
• BullMarket.com Updates Outlooks on CRO Stocks
PRNewswire (Mon, Feb 8)
• Q4 2009 Charles River Laboratories International, Inc. Earnings Release - After Market Close
CCBN (Mon, Feb 8)
More Headlines for CRL...
ANALYST
EPS Est (next year) (Dec-10) : 2.34
EPS Est (in 2 years) (Dec-11) : 2.71
Avg Rec (current)*: 2.5
PEG Ratio: 1.54
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Charles River Laboratories International, Inc. provides research models and laboratory animal support expertise to help its global partners advance their research and drug development efforts.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices